As our understanding of FH deficiency and its role in tumorigenesis evolves, future research is needed to better define the long-term oncological risks associated with FH-deficient tumors, particularly regarding their potential to undergo transformation into leiomyosarcoma. The gene discussed is FH; the disease is leiomyosarcoma.